These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

528 related items for PubMed ID: 33709265

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Neuroprotective effects of rutin against cuprizone-induced multiple sclerosis in mice.
    Nicola MA, Attaai AH, Abdel-Raheem MH, Mohammed AF, Abu-Elhassan YF.
    Inflammopharmacology; 2024 Apr; 32(2):1295-1315. PubMed ID: 38512652
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Myricetin alleviates cuprizone-induced behavioral dysfunction and demyelination in mice by Nrf2 pathway.
    Zhang Q, Li Z, Wu S, Li X, Sang Y, Li J, Niu Y, Ding H.
    Food Funct; 2016 Oct 12; 7(10):4332-4342. PubMed ID: 27713953
    [Abstract] [Full Text] [Related]

  • 8. Multiple functional therapeutic effects of DL-3-n-butylphthalide in the cuprizone model of demyelination.
    Wu Y, Dong L, Huang Q, Sun L, Liao Y, Tang Y, Wu Y.
    Life Sci; 2019 Sep 01; 232():116501. PubMed ID: 31163175
    [Abstract] [Full Text] [Related]

  • 9. Metformin Therapy Attenuates Pro-inflammatory Microglia by Inhibiting NF-κB in Cuprizone Demyelinating Mouse Model of Multiple Sclerosis.
    Abdi M, Pasbakhsh P, Shabani M, Nekoonam S, Sadeghi A, Fathi F, Abouzaripour M, Mohamed W, Zibara K, Kashani IR, Zendedel A.
    Neurotox Res; 2021 Dec 01; 39(6):1732-1746. PubMed ID: 34570348
    [Abstract] [Full Text] [Related]

  • 10. Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination.
    Brück W, Pförtner R, Pham T, Zhang J, Hayardeny L, Piryatinsky V, Hanisch UK, Regen T, van Rossum D, Brakelmann L, Hagemeier K, Kuhlmann T, Stadelmann C, John GR, Kramann N, Wegner C.
    Acta Neuropathol; 2012 Sep 01; 124(3):411-24. PubMed ID: 22766690
    [Abstract] [Full Text] [Related]

  • 11. Repurposing of Secukinumab as Neuroprotective in Cuprizone-Induced Multiple Sclerosis Experimental Model via Inhibition of Oxidative, Inflammatory, and Neurodegenerative Signaling.
    Abdel-Maged AE, Gad AM, Rashed LA, Azab SS, Mohamed EA, Awad AS.
    Mol Neurobiol; 2020 Aug 01; 57(8):3291-3306. PubMed ID: 32514862
    [Abstract] [Full Text] [Related]

  • 12. Trifluoperazine reduces cuprizone-induced demyelination via targeting Nrf2 and IKB in mice.
    Khaledi E, Noori T, Mohammadi-Farani A, Sureda A, Dehpour AR, Yousefi-Manesh H, Sobarzo-Sanchez E, Shirooie S.
    Eur J Pharmacol; 2021 Oct 15; 909():174432. PubMed ID: 34416238
    [Abstract] [Full Text] [Related]

  • 13. Modulating miR-146a Expression by Hydrogen Sulfide Ameliorates Motor Dysfunction and Axonal Demyelination in Cuprizone-Induced Multiple Sclerosis.
    Ghaiad HR, A Abd-Elmawla M, Gad ES, A Ahmed K, Abdelmonem M.
    ACS Chem Neurosci; 2023 Sep 06; 14(17):3047-3058. PubMed ID: 37585620
    [Abstract] [Full Text] [Related]

  • 14. The neuroprotective effects of Chalcones from Ashitaba on cuprizone-induced demyelination via modulation of brain-derived neurotrophic factor and tumor necrosis factor α.
    Rowhanirad S, Taherianfard M.
    Brain Behav; 2023 Sep 06; 13(9):e3144. PubMed ID: 37403256
    [Abstract] [Full Text] [Related]

  • 15. Nebivolol elicits a neuroprotective effect in the cuprizone model of multiple sclerosis in mice: emphasis on M1/M2 polarization and inhibition of NLRP3 inflammasome activation.
    Naeem AG, El-Naga RN, Michel HE.
    Inflammopharmacology; 2022 Dec 06; 30(6):2197-2209. PubMed ID: 35948811
    [Abstract] [Full Text] [Related]

  • 16. Behavioural alterations and morphological changes are attenuated by the lack of TRPA1 receptors in the cuprizone-induced demyelination model in mice.
    Bölcskei K, Kriszta G, Sághy É, Payrits M, Sipos É, Vranesics A, Berente Z, Ábrahám H, Ács P, Komoly S, Pintér E.
    J Neuroimmunol; 2018 Jul 15; 320():1-10. PubMed ID: 29759134
    [Abstract] [Full Text] [Related]

  • 17. MsrA Suppresses Inflammatory Activation of Microglia and Oxidative Stress to Prevent Demyelination via Inhibition of the NOX2-MAPKs/NF-κB Signaling Pathway.
    Fan H, Li D, Guan X, Yang Y, Yan J, Shi J, Ma R, Shu Q.
    Drug Des Devel Ther; 2020 Jul 15; 14():1377-1389. PubMed ID: 32308370
    [Abstract] [Full Text] [Related]

  • 18. Protective Features of Calorie Restriction on Cuprizone-induced Demyelination via Modulating Microglial Phenotype.
    Zarini D, Pasbakhsh P, Nekoonam S, Mojaverrostami S, Ghasemi S, Shabani M, Kashani IR.
    J Chem Neuroanat; 2021 Oct 15; 116():102013. PubMed ID: 34391881
    [Abstract] [Full Text] [Related]

  • 19. Neurobehavioral, biochemical and histological assessment of the effects of resveratrol on cuprizone-induced demyelination in mice: role of autophagy modulation.
    Samy DM, Zaki EI, Hassaan PS, Abdelmonsif DA, Mohamed DY, Saleh SR.
    J Physiol Biochem; 2023 Aug 15; 79(3):583-596. PubMed ID: 37131098
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.